SEC Form 4 · accession 0001127602-16-059725
HAEMONETICS CORP · HAE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher Simon
Officer — President & CEO
Period of report
Aug 4, 2016
Accepted (ET)
Aug 8, 2016 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000313143
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 4, 2016 | P | 60,000 | $34.9959 | A | 105,867 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Simon has 45,867 unvested restricted stock units which are represented here as beneficially owned common stock.